Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,980 | 1 | 66.6% |
| Unspecified | $780.00 | 1 | 26.2% |
| Food and Beverage | $213.32 | 3 | 7.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $2,193 | 4 | $0 (2023) |
| PFIZER INC. | $780.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,193 | 4 | Exelixis Inc. ($2,193) |
| 2020 | $780.00 | 1 | PFIZER INC. ($780.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $41.22 | General |
| Category: Oncology | ||||||
| 08/10/2023 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Oncology | ||||||
| 07/12/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $91.78 | General |
| Category: Oncology | ||||||
| 07/11/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $80.32 | General |
| Category: Oncology | ||||||
| 11/02/2020 | PFIZER INC. | DAURISMO (Drug) | — | In-kind items and services | $780.00 | Research |
| Study: AML CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AML CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
About Dr. Sarah Chirnomas, MD
Dr. Sarah Chirnomas, MD is a Pediatric Hematology-Oncology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326000860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Chirnomas, MD has received a total of $2,973 in payments from pharmaceutical and medical device companies, with $2,193 received in 2023. These payments were reported across 5 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,980).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location New Haven, CT
- Active Since 04/03/2006
- Last Updated 08/13/2010
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1326000860
Products in Payments
- CABOMETYX (Drug) $2,193
- DAURISMO (Drug) $780.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in New Haven
Michael Recht, Md, Phd, MD, PHD
Pediatric Hematology-Oncology — Payments: $357,966
Farzana Pashankar, Mbbs, MBBS
Pediatric Hematology-Oncology — Payments: $31,912
Dr. Prasanna Ananth, Md, Mph, MD, MPH
Pediatric Hematology-Oncology — Payments: $23,496
Dr. Stephanie Massaro, M.d., M.p.h, M.D., M.P.H
Pediatric Hematology-Oncology — Payments: $5,393
Dr. Asher Marks, Md, MD
Pediatric Hematology-Oncology — Payments: $3,926
Nina Kadan-Lottick, Md, MD
Pediatric Hematology-Oncology — Payments: $3,000